Takeda to commercialize Teva's glatiramer in Japan
This article was originally published in Scrip
Executive Summary
Teva and Takeda have disclosed that they signed a Japanese deal earlier this year for Teva's multiple sclerosis (MS) drug glatiramer acetate.